Active ingredients: methylprednisolone
What it is used for
INDICATIONS AS AT 1 JANUARY 1991: MEDROL Tablets (methylprednisolone) are indicated in the following conditions: 1. Endocrine Disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogues may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia. Nonsuppurative thyroiditis. Hypercalcaemia associated with cancer. 2. Rheumatic Disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). Ankylosing spondylitis. Psoriatic arthritis. Acute and subacute bursitis. Epicondylitis Synovitis of osteoarthritis. Acute gouty arthritis. Acute nonspecific tenosynovitis. Post-traumatic osteoarthritis. 3. Collagen Disease: During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus. Systemic dermatomyositis (polymyositis). Acute rheumatic carditis. 4. Dermatologic Diseases: Bullous dermatitis herpetiformis. Pemphigus. Severe erythema multiforme. Severe psoriasis (Stevens-Johnson Syndrome). Severe seborrhoeic dermatitis. Exfoliative dermatitis. Mycosis fungoides. 5. Allergic States: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment: Seasonal or perennial bronchial asthma. Allergic rhinitis, Atopic dermatitis. Drug hypersensitivity reactions. Serum sickness. Contact dermatitis. 6. Ophthalmic Diseases: Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic corneal marginal ulcers. Allergic conjunctivitis. Chorioretinitis. Herpes zoster ophthalmicus. Iritis and iridocyclitis. Anterior segment inflammation. Diffuse posterior uveitis and choroiditis. Sympathetic ophthalmia. Keratitis. Optic neuritis. 7. Respiratory Diseases Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy. Symptomatic sarcoidosis. Berylliosis. Loeffler's syndrome not manageable by other means. Aspiration pneumonitis. 8. Haematologic Disorders: Idiopathic thrombocytopenic purpura in adults. Secondary thrombocytopenia in adults. Acquired (autoimmune) haemolytic anaemia. Erythroblastopenia (RBC anaemia). Congenital (erythroid) hypoplastic anaemia. 9. Neoplastic Diseases: For palliative management of: Leukaemias and lymphomas in adults. Acute leukaemia of childhood. 10. Oedematous States: To induce diuresis or remission of proteinuria in the nephrotic syndrome, without uraemia, of the idiopathic type or that due to lupus erythematosus. 11. Gastrointestinal Diseases: To tide the patient over a critical period of the disease in: Ulcerative colitis. Regional enteritis. 12. Nervous System: Acute exacerbations of multiple sclerosis. 13. Miscellaneous: Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Trichinosis with neurologic or myocardial involvement.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Shelf lifetime is 5 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
white cross-scored tablets marked "MEDROL 4"
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient methylprednisolone
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems